Tcr αβ-depleted progenitor cell graft with additional memory t-cell dli, plus selected use of blinatumomab, in naÏve t-cell depleted haploidentical donor hematopoieitc cell transplantation for hematologic malignancies
Conditions: Acute Lymphoblastic Leukemia (ALL); Acute Myeloid Leukemia (AML); Myelodysplastic Syndromes (MDS); NK-Cell Leukemia; Hodgkin Lymphoma; Non Hodgkin Lymphoma (NHL); Juvenile Myelomonocytic Leukemia (JMML); Chronic Myeloid Leukemia (CML) Interventions: Drug: Cyclophosphamide; Biological: Fludarabine; Drug: Thiotepa; Drug: Melphalan; Biological: G-csf; Drug: Mesna; Device: CliniMACS; Biological: ATG (rabbit); Drug: Blinatumomab; Biological: TCRα/β+; Biological: CD19+; Biological: CD45RA-depleted DLI Sponsor: St. Jude Children's Research Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Children | Hematology | Hospitals | Leukemia | Lymphoma | Research | Transplants